Concepedia

GHR Smith

GS

Statistics

Publications

3

Citations

65

H-Index

3

Active since

2003

Affiliations

Royal Victoria Hospital(Current)

Royal Victoria Regional Health Centre

McGill University Health Centre

GHR Smith is an author at Royal Victoria Hospital specializing in antiretroviral therapy, infectious diseases, and t-cell immune responses.

Publications per year

2003–2017

3

Publications

3

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

Pedro Cahn, Richard Kaplan, Paul E. Sax et al. · The Lancet HIV · 2017 · 35 citations · Full text

, , +15

Interleukin‐7 levels may predict virological response in advanced HIV‐1‐infected patients receiving lopinavir/ritonavir‐based therapy

MR Boulassel, GHR Smith, Norbert Gilmore et al. · HIV Medicine · 2003 · 20 citations

, , +17

Influence of RANTES, SDF‐1 and TGF‐β levels on the value of interleukin‐7 as a predictor of virological response in HIV‐1‐infected patients receiving double boosted protease inhibitor‐based therapy

MR Boulassel, GHR Smith, Mary‐Anne Young et al. · HIV Medicine · 2005 · 10 citations

, , +15

1–3 of 3